Pumps, Pipes & Filters: do SGLT2 inhibitors cover it all?


Concerns about the growing burden of diabetes are mounting. Temporal analyses suggest that cardiovascular risk in people with diabetes persists and, if anything, is widening for fatal outcomes. The need for interventions to prevent diabetes-related complications is clear.

Read More

Verma S, Jüni P, Mazer CD. Lancet 2019;393:3–5.